Carmell Therapeutics Corporation (CTCX)

Overview

Carmell Corporation, initially known as Carmell Therapeutics Corporation, was established in 2008. This transformative shift in branding, taking place in November 2023, symbolizes the company's broader scope within the bio-aesthetics industry, reflecting its commitment to advancing skin and hair health through innovative biotechnology. Operating out of its headquarters in Pittsburgh, Pennsylvania, Carmell Corporation embodies technological innovation and ethical responsibility, standing at the forefront of bio-aesthetic advancements. By harnessing the power of Carmell Secretome, derived from allogeneic human platelets, the company has pioneered a unique approach to skincare and haircare that emphasizes both efficacy and safety, setting a new standard in the sector. Additionally, Carmell Corporation's strategic partnership with Carnegie Mellon University underscores its commitment to cutting-edge research and development, particularly in the realm of biocompatible plasma-based plastics, blending the lines between biological sciences and aesthetic applications.

Products and Services

Carmell Secretome for Skin and Hair Health: Central to Carmell Corporation's product line is the Carmell Secretome, an innovative blend of growth factors and proteins meticulously extracted from allogeneic human platelets. This blend is pivotal in supporting the vitality and wellness of both skin and hair, showcasing the company's dedication to leveraging natural healing mechanisms for cosmetic enhancement. It epitomizes the seamless integration of biotechnology and aesthetic care, providing a solid foundation for their product development.

Microemulsion Formulation: Addressing the industry's growing demand for safer cosmetic formulations, Carmell Corporation has developed an advanced microemulsion technology. This proprietary formulation excels in delivering both lipophilic and hydrophilic ingredients effectively, without the reliance on "The Foul Fourteen" — a list of 14 potentially harmful excipients traditionally used for texture, stability, and other features in cosmetic products. This innovative approach not only ensures product safety but also enhances the overall efficacy of their offerings, marking a significant leap forward in cosmetic science.

Men’s Products Line: Recognizing the unique skincare and haircare needs of men, Carmell Corporation is in the process of developing a dedicated line of products geared specifically towards this demographic. This venture into men’s products showcases the company’s commitment to diversity and inclusivity in beauty and personal care solutions, underscoring a holistic approach to bio-aesthetic development that caters to all genders.

Topical Haircare Products: Building on its expertise in skin health, Carmell Corporation is also venturing into the creation of topical haircare products. Aimed at addressing various hair concerns through scientifically-backed solutions, this line of products is expected to leverage the therapeutic potential of the Carmell Secretome, ensuring hair vitality and strength from the roots to the tips. This expansion signifies the company’s ambition to encompass a broad range of bio-aesthetic needs, providing holistic solutions for both skin and hair care.

Biocompatible Plasma-Based Plastics: Under a licensing agreement with Carnegie Mellon University, Carmell Corporation is at the cutting edge of developing and commercializing biocompatible plasma-based plastics. This endeavor not only highlights the company’s pioneering spirit in the realm of material science but also accentuates its commitment to sustainability and innovation. Through this project, Carmell Corporation is poised to offer revolutionary materials that could redefine the standards of biocompatibility and environmental responsibility in the bio-aesthetics industry and beyond.